Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
Penumbra, Inc. announced 90-day results of the STORM-PE randomized controlled trial (RCT) that is evaluating computer-assisted va ...
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL We conducted a randomized trial of NeuroCARE versus usual care in PMBT caregivers with ...
PuraPly® AM is a patent-protected product that is differentiated among all skin substitutes by combining a native, cross-linked collagen matrix with polyhexamethylene biguanide (PHMB) antimicrobial to ...
LifeNet Health, a global leader in regenerative medicine, has received the Best Randomized Controlled Trial Award at the 2026 CAMPs Awards for its Matrion® diabetic foot ulcer study. In this ...
A controlled trial examines how different protein choices influence metabolic health, offering new insight into diet and ...
85% of the Active Arm and Crossover Arm were classified as responders (≥50% pain reduction) with an average pain reduction of 67%, consistent with previously published data. 28% were high responders ...
It turns out that Tweeting about RCTs 100+ times is a lot easier than delivering even a single RCT.
Felicione is an independent clinical research scientist and principal investigator. Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results